Followers

Sunday, July 19, 2020

Central Drug Agency Seeks Clarification From Glenmark On Its COVID Drug

The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on...

from NDTV News - Special https://ift.tt/3jjsiDu

No comments:

Post a Comment

Loan-related complaints up 43% in FY24, says RBI report

Consumer complaints related to loans and advances rose 43%, representing 29% of the total grievances against RBI-regulated entities in FY24,...